SPAG4
gene geneOn this page
Also known as SUN4CT127
Summary
SPAG4 (sperm associated antigen 4, HGNC:11214) is a protein-coding gene on chromosome 20q11.22, encoding Sperm-associated antigen 4 protein (Q9NPE6). Involved in spermatogenesis.
The mammalian sperm flagellum contains two cytoskeletal structures associated with the axoneme: the outer dense fibers surrounding the axoneme in the midpiece and principal piece and the fibrous sheath surrounding the outer dense fibers in the principal piece of the tail. Defects in these structures are associated with abnormal tail morphology, reduced sperm motility, and infertility. In the rat, the protein encoded by this gene associates with an outer dense fiber protein via a leucine zipper motif and localizes to the microtubules of the manchette and axoneme during sperm tail development. Alternative splicing results in multiple transcript variants encoding different isoforms.
Source: NCBI Gene 6676 — RefSeq curated summary.
At a glance
- GWAS associations: 5
- Clinical variants (ClinVar): 46 total
- MANE Select transcript:
NM_003116
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:11214 |
| Approved symbol | SPAG4 |
| Name | sperm associated antigen 4 |
| Location | 20q11.22 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | SUN4, CT127 |
| Ensembl gene | ENSG00000061656 |
| Ensembl biotype | protein_coding |
| OMIM | 603038 |
| Entrez | 6676 |
Gene structure
Transcript identifiers
Ensembl transcripts: 10 — 6 protein_coding, 3 retained_intron, 1 protein_coding_CDS_not_defined
ENST00000374273, ENST00000430878, ENST00000454819, ENST00000462896, ENST00000463973, ENST00000468248, ENST00000498203, ENST00000679710, ENST00000861575, ENST00000957539
RefSeq mRNA: 2 — MANE Select: NM_003116
NM_001317931, NM_003116
CCDS: CCDS13259, CCDS93032
Canonical transcript exons
ENST00000374273 — 12 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000661664 | 35617136 | 35617240 |
| ENSE00000661668 | 35618612 | 35618720 |
| ENSE00001462991 | 35615829 | 35616307 |
| ENSE00003460654 | 35617520 | 35617586 |
| ENSE00003509639 | 35618087 | 35618130 |
| ENSE00003514447 | 35618923 | 35618998 |
| ENSE00003543101 | 35619579 | 35619746 |
| ENSE00003544571 | 35619195 | 35619310 |
| ENSE00003550634 | 35618450 | 35618475 |
| ENSE00003555690 | 35617779 | 35617840 |
| ENSE00003556755 | 35620684 | 35620773 |
| ENSE00003891747 | 35620876 | 35621094 |
Expression profiles
Bgee: expression breadth ubiquitous, 186 present calls, max score 96.26.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 3.9955 / max 59.7410, expressed in 1320 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 184313 | 2.3319 | 1016 |
| 184311 | 0.6065 | 278 |
| 184314 | 0.5075 | 229 |
| 184315 | 0.4345 | 195 |
| 184312 | 0.1152 | 51 |
Top tissues by expression
278 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| body of pancreas | UBERON:0001150 | 96.26 | gold quality |
| right testis | UBERON:0004534 | 93.87 | gold quality |
| left testis | UBERON:0004533 | 93.68 | gold quality |
| testis | UBERON:0000473 | 90.83 | gold quality |
| pancreas | UBERON:0001264 | 86.58 | gold quality |
| adenohypophysis | UBERON:0002196 | 85.34 | gold quality |
| left ovary | UBERON:0002119 | 85.19 | gold quality |
| right ovary | UBERON:0002118 | 84.30 | gold quality |
| left uterine tube | UBERON:0001303 | 84.12 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 83.79 | gold quality |
| spleen | UBERON:0002106 | 83.16 | gold quality |
| pituitary gland | UBERON:0000007 | 82.96 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 81.95 | gold quality |
| transverse colon | UBERON:0001157 | 81.45 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 81.40 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 81.37 | gold quality |
| body of stomach | UBERON:0001161 | 81.06 | gold quality |
| endocervix | UBERON:0000458 | 80.98 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 80.86 | gold quality |
| minor salivary gland | UBERON:0001830 | 80.56 | gold quality |
| right adrenal gland | UBERON:0001233 | 80.05 | gold quality |
| adrenal tissue | UBERON:0018303 | 80.04 | gold quality |
| stromal cell of endometrium | CL:0002255 | 79.98 | gold quality |
| bone marrow cell | CL:0002092 | 79.73 | gold quality |
| left adrenal gland | UBERON:0001234 | 79.51 | gold quality |
| small intestine | UBERON:0002108 | 79.38 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 79.11 | gold quality |
| ovary | UBERON:0000992 | 78.78 | gold quality |
| gall bladder | UBERON:0002110 | 78.60 | gold quality |
| apex of heart | UBERON:0002098 | 78.49 | gold quality |
Single-cell (SCXA)
Detected in 9 experiment(s), a significant marker in 8.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-CURD-88 | yes | 107.84 |
| E-HCAD-4 | yes | 39.46 |
| E-ANND-3 | yes | 34.19 |
| E-MTAB-8410 | yes | 32.41 |
| E-CURD-46 | yes | 31.72 |
| E-HCAD-11 | yes | 20.16 |
| E-MTAB-10553 | yes | 11.02 |
| E-HCAD-1 | yes | 10.45 |
| E-MTAB-6108 | no | 223.43 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 6)
- SPAG4 is an independent prognostic factor in renal cell carcinoma and plays a crucial role in cytokinesis to defend against hypoxia-induced tetraploid formation. (PMID:23602831)
- SPAG4 knockdown reduces the invasion capability of RCC cells. (PMID:23818324)
- SPAG4, in cooperation with Nesprin3, has a fundamental pathological function in the migration of lung carcinoma cells. (PMID:29901114)
- Our study revealed that SPAG4 was identified as a cancer biomarker for glioblastoma and might be a promising target for clinical diagnosis and intervention of glioblastoma. (PMID:30817682)
- Results indicate that sperm associated antigen 4 (SPAG4L/SPAG4Lbeta) transcript isoform interacts with spectrin repeat containing nuclear envelope protein 2 (Nesprin2) in the meiotic process. (PMID:31144711)
- Human sperm-associated antigen 4 as a potential prognostic biomarker of lung squamous cell carcinoma. (PMID:34311595)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Spag4 | ENSMUSG00000038180 |
| rattus_norvegicus | Spag4 | ENSRNOG00000048056 |
| caenorhabditis_elegans | WBGENE00006816 |
Paralogs (4): SUN2 (ENSG00000100242), SUN3 (ENSG00000164744), SUN1 (ENSG00000164828), SUN5 (ENSG00000167098)
Protein
Protein identifiers
Sperm-associated antigen 4 protein — Q9NPE6 (reviewed: Q9NPE6)
Alternative names: Outer dense fiber-associated protein SPAG4, SUN domain-containing protein 4
All UniProt accessions (4): Q9NPE6, A0A7P0Z4G5, C9JJZ6, Q5JX49
UniProt curated annotations — full annotation on UniProt →
Function. Involved in spermatogenesis. Required for sperm head formation but not required to establish and maintain general polarity of the sperm head. Required for anchoring and organization of the manchette. Required for targeting of SUN3 and probably SYNE1 through a probable SUN1:SYNE3 LINC complex to the nuclear envelope and involved in accurate posterior sperm head localization of the complex. May anchor SUN3 the nuclear envelope. Involved in maintenance of the nuclear envelope integrity. May assist the organization and assembly of outer dense fibers (ODFs), a specific structure of the sperm tail.
Subunit / interactions. Homodimer. Interacts with ODF1. May associate with microtubules. Interacts with SUN3 and SYNE1; suggesting the formation of a spermatogenesis-specific LINC complex; a SUN domain-based heterotrimer with SUN3 may associate with SYNE1. Interacts with SEPT12 and LMNB1; during spermatogenesis.
Subcellular location. Membrane. Cytoplasm. Cytoskeleton. Flagellum axoneme. Nucleus envelope. Nucleus inner membrane.
Tissue specificity. Predominantly epressed in testis. Expressed in ejaculated spermatozoa (at protein level).
RefSeq proteins (2): NP_001304860, NP_003107* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR012919 | SUN_dom | Domain |
| IPR045119 | SUN1-5 | Family |
Pfam: PF07738
UniProt features (9 total): compositionally biased region 3, transmembrane region 2, chain 1, domain 1, region of interest 1, coiled-coil region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9NPE6-F1 | 71.79 | 0.38 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 123 (showing top):
NIKOLSKY_BREAST_CANCER_20Q11_AMPLICON, GOZGIT_ESR1_TARGETS_DN, MENSE_HYPOXIA_UP, GOBP_MALE_GAMETE_GENERATION, LIAO_METASTASIS, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, HAN_SATB1_TARGETS_DN, chr20q11, GOCC_NUCLEAR_ENVELOPE, GOCC_ORGANELLE_INNER_MEMBRANE, GOCC_NUCLEAR_INNER_MEMBRANE, GOCC_MEMBRANE_PROTEIN_COMPLEX, GOCC_NUCLEAR_MEMBRANE, ZHAN_MULTIPLE_MYELOMA_CD2_UP, GOMF_STRUCTURAL_MOLECULE_ACTIVITY
GO Biological Process (2): spermatogenesis (GO:0007283), cell differentiation (GO:0030154)
GO Molecular Function (3): structural molecule activity (GO:0005198), protein-membrane adaptor activity (GO:0043495), protein binding (GO:0005515)
GO Cellular Component (10): nuclear envelope (GO:0005635), nuclear inner membrane (GO:0005637), cytoskeleton (GO:0005856), meiotic nuclear membrane microtubule tethering complex (GO:0034993), nucleus (GO:0005634), cytoplasm (GO:0005737), cilium (GO:0005929), membrane (GO:0016020), motile cilium (GO:0031514), cell projection (GO:0042995)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| developmental process involved in reproduction | 1 |
| male gamete generation | 1 |
| cellular developmental process | 1 |
| molecular_function | 1 |
| protein-macromolecule adaptor activity | 1 |
| binding | 1 |
| nucleus | 1 |
| endomembrane system | 1 |
| organelle envelope | 1 |
| organelle inner membrane | 1 |
| nuclear membrane | 1 |
| intracellular membraneless organelle | 1 |
| microtubule organizing center attachment site | 1 |
| nuclear membrane microtubule tethering complex | 1 |
| intracellular membrane-bounded organelle | 1 |
| intracellular anatomical structure | 1 |
| intraciliary transport particle | 1 |
| membrane-bounded organelle | 1 |
| plasma membrane bounded cell projection | 1 |
| cilium | 1 |
Protein interactions and networks
STRING
1212 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SPAG4 | ODF1 | Q14990 | 998 |
| SPAG4 | SPAG5 | Q96R06 | 737 |
| SPAG4 | SYNE1 | Q8NF91 | 737 |
| SPAG4 | SYNE3 | Q6ZMZ3 | 636 |
| SPAG4 | SYNE4 | Q8N205 | 587 |
| SPAG4 | SEPTIN12 | Q8IYM1 | 543 |
| SPAG4 | SYNE2 | Q8WXH0 | 532 |
| SPAG4 | KASH5 | Q8N6L0 | 530 |
| SPAG4 | SEPTIN1 | Q8WYJ6 | 475 |
| SPAG4 | SEPTIN6 | Q14141 | 471 |
| SPAG4 | EMD | P50402 | 447 |
| SPAG4 | HOOK1 | Q9UJC3 | 443 |
| SPAG4 | TOR3A | Q9H497 | 442 |
| SPAG4 | MRPS18A | Q9NVS2 | 441 |
| SPAG4 | OTOR | Q9NRC9 | 439 |
IntAct
88 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SEPTIN12 | SPAG4 | psi-mi:“MI:0915”(physical association) | 0.610 |
| SPAG4 | SEPTIN12 | psi-mi:“MI:0915”(physical association) | 0.610 |
| SEPTIN12 | SPAG4 | psi-mi:“MI:0403”(colocalization) | 0.610 |
| TMEM120A | SPAG4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZDHHC24 | SPAG4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SLC30A8 | SPAG4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CYP4F2 | SPAG4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ABHD16A | SPAG4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM60 | SPAG4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PGA4 | SPAG4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GOSR2 | SPAG4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ASGR1 | SPAG4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| IGFBP5 | SPAG4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TSPO2 | SPAG4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MS4A13 | SPAG4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM187 | SPAG4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PTPN9 | SPAG4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SEC22A | SPAG4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| BMP10 | SPAG4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TNMD | SPAG4 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (31): SPAG4 (Two-hybrid), SCD (Two-hybrid), ERMP1 (Two-hybrid), GOSR2 (Two-hybrid), TSPO2 (Two-hybrid), IGFBP5 (Two-hybrid), SEC22A (Two-hybrid), TMEM60 (Two-hybrid), NRM (Two-hybrid), C16orf58 (Two-hybrid), ASGR1 (Two-hybrid), CSGALNACT1 (Two-hybrid), BMP10 (Two-hybrid), SUN5 (Two-hybrid), PTPN9 (Two-hybrid)
ESM2 similar proteins: A1L3T7, A2CI98, A2CJ06, A2VCK2, D3ZQL6, E1BBG2, M3WHG5, O15037, O43918, O70303, O75333, P48778, P59729, Q32PJ7, Q3KP66, Q3T191, Q5JYT7, Q5T124, Q5U4F0, Q5XIS1, Q6AXX1, Q6VYH9, Q7TSI1, Q80U38, Q8BGT6, Q8BHW9, Q8BWG4, Q8BWQ5, Q8BZ33, Q8BZW2, Q8C0J6, Q8C2K5, Q8CFK6, Q8IV53, Q8IY33, Q8IZW8, Q8K1S6, Q8K330, Q8N3F8, Q8TB24
Diamond homologs: A0A0B4KEE4, O55034, O94901, Q09825, Q0II64, Q20745, Q5SS91, Q8BJS4, Q8TAQ9, Q8TC36, Q95LV7, Q9D666, Q9DA32, Q9JJF2, Q9NPE6, Q9UH99, Q9SG79, Q558Z2, Q9FF75
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| SPAG4 | “form complex” | “LINC complex” | binding |
Disease & clinical
Clinical variants and AI predictions
ClinVar
46 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 36 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1760 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 20:35618611:GTGA:G | acceptor_gain | 1.0000 |
| 20:35619193:A:AG | acceptor_gain | 1.0000 |
| 20:35619194:G:GG | acceptor_gain | 1.0000 |
| 20:35619307:GGAG:G | donor_gain | 1.0000 |
| 20:35619308:GAG:G | donor_gain | 1.0000 |
| 20:35619308:GAGG:G | donor_gain | 1.0000 |
| 20:35619309:AGGT:A | donor_loss | 1.0000 |
| 20:35619310:GGTG:G | donor_loss | 1.0000 |
| 20:35619311:G:C | donor_loss | 1.0000 |
| 20:35620679:ACCAG:A | acceptor_gain | 1.0000 |
| 20:35620680:CCA:C | acceptor_loss | 1.0000 |
| 20:35620681:CA:C | acceptor_loss | 1.0000 |
| 20:35620682:A:AG | acceptor_gain | 1.0000 |
| 20:35620683:G:GG | acceptor_gain | 1.0000 |
| 20:35620683:G:GT | acceptor_loss | 1.0000 |
| 20:35616224:G:GT | donor_gain | 0.9900 |
| 20:35618085:A:AG | acceptor_gain | 0.9900 |
| 20:35618086:G:GG | acceptor_gain | 0.9900 |
| 20:35618086:GC:G | acceptor_gain | 0.9900 |
| 20:35618131:G:GG | donor_gain | 0.9900 |
| 20:35618610:A:AG | acceptor_gain | 0.9900 |
| 20:35618611:G:GG | acceptor_gain | 0.9900 |
| 20:35618611:GT:G | acceptor_gain | 0.9900 |
| 20:35619039:A:T | donor_gain | 0.9900 |
| 20:35619189:TTCCA:T | acceptor_loss | 0.9900 |
| 20:35619192:CA:C | acceptor_loss | 0.9900 |
| 20:35619193:A:AC | acceptor_loss | 0.9900 |
| 20:35619194:GGA:G | acceptor_gain | 0.9900 |
| 20:35619306:TGGAG:T | donor_gain | 0.9900 |
| 20:35619307:GGAGG:G | donor_gain | 0.9900 |
AlphaMissense
2828 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 20:35619605:G:C | W312C | 0.997 |
| 20:35619605:G:T | W312C | 0.997 |
| 20:35620762:T:C | F386L | 0.997 |
| 20:35620764:C:A | F386L | 0.997 |
| 20:35620764:C:G | F386L | 0.997 |
| 20:35620726:T:C | F374L | 0.996 |
| 20:35620728:C:A | F374L | 0.996 |
| 20:35620728:C:G | F374L | 0.996 |
| 20:35619603:T:A | W312R | 0.994 |
| 20:35619603:T:C | W312R | 0.994 |
| 20:35620910:T:C | I401T | 0.994 |
| 20:35619637:T:C | I323T | 0.993 |
| 20:35620732:T:C | F376L | 0.993 |
| 20:35620734:C:A | F376L | 0.993 |
| 20:35620734:C:G | F376L | 0.993 |
| 20:35619610:T:G | F314C | 0.991 |
| 20:35620916:T:C | I403T | 0.991 |
| 20:35620942:T:C | F412L | 0.991 |
| 20:35620944:C:A | F412L | 0.991 |
| 20:35620944:C:G | F412L | 0.991 |
| 20:35620964:G:C | R419P | 0.991 |
| 20:35619637:T:A | I323N | 0.990 |
| 20:35620894:T:C | F396L | 0.990 |
| 20:35620896:T:A | F396L | 0.990 |
| 20:35620896:T:G | F396L | 0.990 |
| 20:35619610:T:C | F314S | 0.989 |
| 20:35620910:T:G | I401S | 0.989 |
| 20:35620926:C:A | N406K | 0.989 |
| 20:35620926:C:G | N406K | 0.989 |
| 20:35620961:T:A | V418D | 0.989 |
dbSNP variants (sampled 300 via entrez): RS1000461465 (20:35617942 C>T), RS1001009870 (20:35619406 G>A,T), RS1001093449 (20:35616488 A>G), RS1001619666 (20:35620096 G>A), RS1001634950 (20:35617450 G>T), RS1002904029 (20:35616105 C>T), RS1003281922 (20:35616379 G>A,C), RS1003293841 (20:35621304 T>C), RS1003429631 (20:35621117 A>T), RS1004081884 (20:35615727 C>A), RS1004184895 (20:35614125 C>T), RS1005606698 (20:35619131 GCCCCCGCGCCCCGACT>G), RS1006149514 (20:35620281 T>A), RS1006323140 (20:35620532 C>T), RS1006518851 (20:35618745 C>A,G,T)
Disease associations
OMIM: gene MIM:603038 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
5 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST005956_31 | Waist-to-hip ratio adjusted for BMI | 8.000000e-08 |
| GCST005958_16 | Waist-to-hip ratio adjusted for BMI (age >50) | 6.000000e-06 |
| GCST005962_40 | Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test) | 3.000000e-08 |
| GCST010002_66 | Refractive error | 2.000000e-20 |
| GCST010703_112 | Brain morphology (MOSTest) | 4.000000e-19 |
EFO canonical traits (4, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007788 | BMI-adjusted waist-hip ratio |
| EFO:0008007 | age at assessment |
| EFO:0008343 | sex interaction measurement |
| EFO:0004346 | neuroimaging measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
40 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Cyclosporine | decreases expression | 3 |
| mercuric bromide | decreases expression, affects cotreatment | 2 |
| bisphenol S | affects cotreatment, increases expression, decreases expression | 2 |
| Benzo(a)pyrene | increases expression, increases methylation | 2 |
| Phenylmercuric Acetate | affects cotreatment, decreases expression | 2 |
| Smoke | decreases expression, increases abundance | 2 |
| Valproic Acid | increases methylation, affects expression | 2 |
| aristolochic acid I | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | affects expression | 1 |
| tris(2-butoxyethyl) phosphate | affects expression | 1 |
| arsenite | affects binding, increases reaction | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | decreases expression | 1 |
| zinc chloride | increases expression, decreases reaction | 1 |
| cobaltous chloride | increases expression, decreases reaction | 1 |
| nickel chloride | increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| NSC 689534 | increases expression | 1 |
| Air Pollutants | increases abundance, decreases expression | 1 |
| Benzene | increases expression | 1 |
| Carbamazepine | affects expression | 1 |
| Dexamethasone | affects cotreatment, increases expression | 1 |
| Diethylhexyl Phthalate | decreases expression | 1 |
| Estradiol | affects cotreatment, increases expression | 1 |
| Hydrogen Peroxide | affects expression | 1 |
| Indomethacin | increases expression, affects cotreatment | 1 |
| Oxygen | increases expression | 1 |
| Quercetin | affects expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.